Karabulut B - Search Results

1

A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.

Kurt E, Cubukcu E, Karabulut B, Olmez OF, Kurt M, Avci N, Ozdemir F, Tunali D, Evrensel T, Manavoglu O. Kurt E, et al. Among authors: karabulut b. J BUON. 2013 Jan-Mar;18(1):147-53. J BUON. 2013. PMID: 23613400 Free article.

2

Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma.

Kurt E, Sezgin C, Evrensel T, Yalcinkaya U, Kanat O, Veral A, Demiray M, Arslan M, Karabulut B, Ercan I, Goker E, Manavoglu O. Kurt E, et al. Among authors: karabulut b. Int J Clin Pract. 2005 May;59(5):537-43. doi: 10.1111/j.1368-5031.2005.00447.x. Int J Clin Pract. 2005. PMID: 15857349

3

Topotecan in platinum-resistant epithelial ovarian cancer.

Karabulut B, Sezgin C, Terek MC, Uslu R, Sanli UA, Akman L, Ozsaran A, Dikmen Y, Goker E. Karabulut B, et al. Chemotherapy. 2005 Oct;51(6):347-51. doi: 10.1159/000088959. Epub 2005 Oct 14. Chemotherapy. 2005. PMID: 16227688

4

Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors.

Sezgin C, Karabulut B, Uslu R, Sanli UA, Goksel G, Yuzer Y, Goker E. Sezgin C, et al. Among authors: karabulut b. Scand J Gastroenterol. 2005 Dec;40(12):1486-92. doi: 10.1080/00365520510023819. Scand J Gastroenterol. 2005. PMID: 16293561

5

Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.

Kucukzeybek Y, Gorumlu G, Karaca B, Erten C, Cengiz E, Kemal Gul M, Karabulut B, Uslu R, Sanli UA, Goker E. Kucukzeybek Y, et al. Among authors: karabulut b. J BUON. 2008 Apr-Jun;13(2):199-203. J BUON. 2008. PMID: 18555465

6

Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients.

Gorumlu G, Kucukzeybek Y, Kemal-Gul M, Karaca B, Cosan-Terek M, Karabulut B, Sanli UA, Akman L, Ozsaran A, Dikmen Y, Uslu R. Gorumlu G, et al. Among authors: karabulut b. J BUON. 2008 Jul-Sep;13(3):349-52. J BUON. 2008. PMID: 18979548

7

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer.

Degirmenci M, Karaca B, Gorumlu G, Durusoy R, Demir Piskin G, Bozkurt MT, Cirak Y, Tunali D, Karabulut B, Sanli UA, Uslu R. Degirmenci M, et al. Among authors: karabulut b. Med Oncol. 2010 Sep;27(3):585-91. doi: 10.1007/s12032-009-9253-5. Epub 2009 Jun 13. Med Oncol. 2010. PMID: 19526201 Review.

8

Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7.

Karaca B, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Uslu R. Karaca B, et al. Among authors: karabulut b. J BUON. 2009 Jul-Sep;14(3):479-85. J BUON. 2009. PMID: 19810142

9

The effect of racemic gossypol and at-101 on angiogenic profile of ovcar-3 cells: a preliminary molecular framework for gossypol enantiomers.

Varol U, Karaca B, Tunali D, Degirmenci M, Cirak Y, Purcu DU, Uzunoglu S, Sezgin C, Karabulut B, Sanli UA, Uslu R. Varol U, et al. Among authors: karabulut b. Exp Oncol. 2009 Dec;31(4):220-5. Exp Oncol. 2009. PMID: 20010531

10

Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment.

Akagunduz O, Karaca B, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Haydaroglu A, Uslu R. Akagunduz O, et al. Among authors: karabulut b. J BUON. 2010 Oct-Dec;15(4):763-7. J BUON. 2010. PMID: 21229643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters